21st North

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company is headquartered in Minneapolis, Minnesota and currently employs 61 full-time employees. The firm is engaged in providing a range of services and project management for the mineral industry. The company offers its clients multidisciplinary solutions combining geological knowledge with the latest exploration tools. Its services include office services and data management, and contract exploration. Its office services and data management services include property appraisal and independent valuations, report writing and resource compilations, exploration strategy, target generation and development, and outlining and supervision of metallurgical test work programs. Its contract exploration services include geological prospecting, exploration and mapping, project management / site management and geological staffing, and supervision and management of ground/airborne geophysical surveys.